Rep. Robert P. Bresnahan, Jr. sold Incyte (INCY)
Rep. Robert P. Bresnahan, Jr. (R-PA-8) · $1K–$15K · traded May 15, 2025
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- May 15, 2025
- Disclosed
- May 31, 2025
- Days to disclose
- 16
- Asset type
- Stock
- As filed
- Incyte Corporation - Common Stock
- Industry
- Biotechnology · Healthcare
Other trades in this filing
All of Bresnahan's trades →- May 31, 2025$1K–$15K
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$15K–$50K
Bought Advanced Micro Devices AMD
$15K–$50K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$15K–$50K
$15K–$50K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
Bought Mettler-Toledo International MTD
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
Sold Zimmer Biomet Holdings ZBH
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$15K–$50K
$15K–$50K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$15K–$50K
$15K–$50K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$15K–$50K
$15K–$50K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
Got $8K from the company’s PAC - May 31, 2025$1K–$15K
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
Sold International Flavors & Fragrances IFF
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
Sold Charles River Laboratories International CRL
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
Bought GE HealthCare Technologies GEHC
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$15K–$50K
Bought Thermo Fisher Scientific TMO
$15K–$50K · Traded May 15, 2025 · disclosed May 31, 2025
- May 31, 2025$1K–$15K
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
Recent Congress trades in INCY
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Nov 8, 2023$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 10, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Dec 8, 2018$1K–$15K
Sen. Shelley Moore Capito (R-WV)
$1K–$15K · Traded Nov 12, 2018 · disclosed Dec 8, 2018 · Spouse
- Oct 6, 2017$1K–$15K
Sen. Shelley Moore Capito (R-WV)
$1K–$15K · Traded Sep 8, 2017 · disclosed Oct 6, 2017 · Spouse
Company context for INCY
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
INCY: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
INCY: Financial results
Filed 8-K for an event or period dated 2026-10-29. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.